Company: PFSA
Filing Date: 2025-02-12
Form Type: S-4/A
Source: 0001213900-25-012354
Chunk: 243

Company: Profusa, Inc.
Filing Date: 2025-02-12
Form: S-4/A
Chunk 243
---
 a brief description of the material background of these negotiations, the Business Combination and related transactions. On December 22, 2021, NorthView completed the NorthView Acquisition Corporation’s IPO of 18,975,000 units (the “Units”), which included 2,475,000 Units issued pursuant to the full exercise of the over -allotmentoption granted to the underwriters. Each Unit consists of one share of common stock of the Company, par value $0.0001 per share, one right (the “Rights”), and one -halfof one redeemable warrant of the Company (the “Warrants”). Each Right entitles the holder thereof to receive one -tenthof one share of common stock. Each Warrant entitles the holder thereof to purchase one share of common stock for $11.50 per share, subject to adjustment. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $189,750,000. Simultaneous with the closing of the IPO, NorthView completed the private sale of an aggregate of 7,347,500 warrants (the “Private Placement Warrants”) to Sponsor, I -BankersSecurities, Inc. (“I -Bankers”), and Dawson James Securities, Inc. at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $7,347,500. The Private Placement Warrants are identical to the Warrants sold in the IPO except that the Private Placement Warrants: (i) will not be redeemable by the Company and (ii) may be exercised for cash or on a cashless basis, as described in the Registration Statement, in each case so long as they are held by the initial purchasers or any of their permitted transferees. If the private placement warrants are held by holders other than the initial purchasers or any of their permitted transferees, the private placement warrants will be redeemable by NorthView and exercisable by the holders on the same basis as the warrants included in the Units sold in the IPO. No underwriting discounts or commissions were paid with respect to such sale. 116 A total of $191,647,500 of the proceeds from the IPO (including the full exercise of the over -allotmentoption) and the sale of the Private Placement Warrants were placed in a U.S. -basedtrust account maintained by Continental Stock Transfer & Trust Company, acting as trustee. In connection with a special meeting